Product Code: GMD FDA class 2 21 CFR 866.3165

Antisera, Latex Agglutination, Cryptococcus Neoformans

Microbiology

The Latex Agglutination Antisera for Cryptococcus Neoformans is a microbiology reagent used to detect capsular antigens or antibodies associated with Cryptococcus neoformans, a pathogenic fungus responsible for cryptococcal meningitis and other serious infections. It is classified as FDA Class 2 (moderate risk) and requires 510(k) premarket clearance. The product code is GMD, regulated under 21 CFR 866.3165 in the Microbiology specialty.

510(k)s
10
FEI Numbers
7
Registration Numbers
7
Unique Applicants
6
Years Active
34

Research product code GMD in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
GMD
Device Class
FDA class 2
Regulation Number
866.3165
Medical Specialty
Microbiology
Review Panel
MI
Submission Type
4

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 10 510(k) clearances via K numbers.

K Number Device Name
K112422 CRAG LATERAL FLOW ASSAY (LFA)
K102286 CRAG LATERAL FLOW ASSAY (CRAG LFA)
K930418 CRYPTO-LEX SYSTEM
K933997 PROSPECT ENTAMOEBA HISTOLYTICA MICROPLATE ASSAY
K894845 (CALAS(TM)) W/ADD'L REAGENT CALAS(TM) PRONASE
K812188 CRYPTOCOCCAL ANTIGEN LATEX AGGLUTI
K810510 YA-CRYPTO ANTIBODY TUBE AGGLUTINATION
K792693 CRYPTOCOCCUS NEOFORMANS ANTISERUM, LATEX
K791382 CRYPTOCOCCAL ANTIGEN LATEX AGGLUTINATION
K780526 CRYPTOCOCCAL ANTIGEN LATEX AGG. SYSTEM

FEI Numbers

This FDA classification entry is associated with 7 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 7 registration numbers. Click on an entry to view related FDA registrations.